Geron Announced FDA Provided Notice That It Scheduled Advisory Committee Meeting Of Oncologic Drugs Advisory Committee As Part Of NDA Review

Geron Corporation -0.29%

Geron Corporation

GERN

3.48

-0.29%

-SEC Filing

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via